Serono Symposia International Foundation adheres to guidelines of the European Accreditation Council for Continuing Medical Education (EACCME) and all other professional organizations, as applicable, which state that programs awarding continuing education credits must be balanced, independent, objective, and scientifically rigorous. Investigative and other uses for pharmaceutical agents, medical devices, and other products (other than those uses indicated in approved product labeling/package insert for the product) may be presented in the program (which may reflect clinical experience, the professional literature or other clinical sources known to the presenter). We ask all presenters to provide participants with information about relationships with pharmaceutical or medical equipment companies that may have relevance to their lectures. This policy is not intended to exclude faculty who have relationships with such companies; it is only intended to inform participants of any potential conflicts so participants may form their own judgments, based on full disclosure of the facts. Further, all opinions and recommendations presented during the program and all program-related materials neither imply an endorsement, nor a recommendation, on the part of Serono Symposia International Foundation. All presentations solely represent the independent views of the presenters/authors.
The following faculty provided information regarding significant commercial relationships and/or discussions of investigational or non-EMEA/FDA approved (off-label) uses of drugs:
David Agudo Garcillán: Declared no potential conflict of interest.
Carlos Balmori Boticario: Declared no potential conflict of interest.
Jose Bellver Pradas: Declared no potential conflict of interest.
Ernesto Bosch Aparicio: Declared to be member of Advisory Board, Board of Directors or other similar group of Merck-Serono, Shering-Plough and declared to participated in a company sponsored speaker's bureau: Merck-Serono satellite Symposium in ESHRE 2009.
Fernando Bronet Campos: Declared no potential conflict of interest.
Robert Fischer: Declared receipt of honoraria or consulations fees from Serono Symposia International Foundation and to be member of the Scientific Committee of Serono Symposia International Foundation.
Silvia Gonzàlez Juanmarti: Declared no potential conflict of interest.
Antonio Gosàlvez: Declared no potential conflict of interest.
Diana Guerra Diaz: Declared no potential conflict of interest.
Stuart Lavery: Declared no potential conflict of interest.
Yolanda Minguez Royo: Declared no potential conflict of interest.
Luciano Giovanni Nardo: Declared receipt of research and educational grants from Merck Serono and receipt of honoraria from Merck Serono.
Antonio Pellicer Martínez: Declared no potential conflict of interest.
José Remohí Giménez: Declared no potential conflict of interest.
Raphael Ron-El: Declared no potential conflict of interest.
Hassan Nooman Sallam: Declared no potential conflict of interest.
Carlos Simón Vallés: Declared no potential conflict of interest.
Kok Joo Thong: Declared receipt of grants from Merck Serono
Juan Antonio García-Velasco: Declared no potential conflict of interest.
The following faculty have provided no information regarding significant relationship with commercial supporters and/or discussion of investigational or non-EMEA/FDA approved (off-label) uses of drugs as of November 28,2009.
Alfredo Guillén
